Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1234 | Obesity | ICEECE2012

How informative is visceral fat measurement by bioelectrical impedance?

Mousa U. , Kut A. , Bozkus Y. , Cicek Demir C. , Anil C. , Bascil Tutuncu N.

Although obesity is a powerful risk factor for developing metabolic syndrome (MetS), it is not present in all obese individuals. Increased visceral adipose tissue is the hallmark of this syndrome. In this cross sectional survey abdominal bioelectrical impedence was used to measure the visceral adipose tissue (VAT) and trunk fat percentages (TF%) in participants. A total of 286 patients (196 female and 90 males) were enrolled in the study. In both sexes VAT was significantly po...

ea0029p1651 | Thyroid (non-cancer) | ICEECE2012

Evaluation of health related quality of life and general symptoms in Hashimoto's thyroiditis: are factors other than thyroid function effective? Analysis of preliminary results

Anil C. , Kut A. , Demir C. , Mousa U. , Bozkus Y. , Bascil Tutuncu N.

Introduction: Factors affecting health related quality of life (HRQOL) in HashimotoÂ’s thyroiditis (HT) are controversial and research on the topic is limited. This study aimed to evaluate the factors that may affect HRQOL and admitting symptoms in a group of patients with HT.Methods: For the evaluation of HRQOL, SF-36, Beck anxiety scale and Beck depression scale were performed on subsequent 57 cases with HT admitting to outpatient clinic of Endocri...

ea0029p714 | Diabetes | ICEECE2012

Antidiabetic therapies and malignancy: a retrospective study in oncological cases.

Anil C. , Demir C. , Erismis B. , Can S. , Yalcin S. , Altundag O. , Gunes G. , Bascil Tutuncu N.

Introduction: Despite the relation between Type 2 Diabetes Mellitus (DM) and development of malignancy is well known, data on antidiabetic drugs and cancer risk is contradictory. Thesis which have suggested that analogue insulins, especially glargine, increase cancer risk, has not been validated. The present study aimed to evaluate the possible contributions of diabetes durations and medications to the type and course of malignancy in patients with both diabetes and malignancy...